هجرت
پخش هجرت
سود 3 Months :
| سهامدار | نوع معامله | حجم معامله | زمان انتشار | منبع |
|---|---|---|---|---|
 صندوق سرمایه گذاری مشترک پیشرومفید | خرید | 4.800 میلیون | 9/2/2025 |  شرکت مدیریت فناوری سازمان بورس |
شرکت سرمایه گذاری داروئی تامین | خرید | 3254.644 میلیون | 8/13/2025 | شرکت مدیریت فناوری سازمان بورس |
شرکت داروسازی فارابی | خرید | 4615.478 میلیون | 8/13/2025 | شرکت مدیریت فناوری سازمان بورس |
شرکت داروسازی تهران شیمی | خرید | 4427.465 میلیون | 8/13/2025 | شرکت مدیریت فناوری سازمان بورس |
شرکت پارس دارو | خرید | 2311.215 میلیون | 8/13/2025 | شرکت مدیریت فناوری سازمان بورس |
پیامهای هجرت
صندوق سرمایه گذاری مشترک پیشرومفید
The Pleutory Joint Investment Fund purchased 4.800 million shares of Hijra on 14/06/11 and currently holds 1.038 % of Hijra's shares in its joint portfolio.
شرکت سرمایه گذاری داروئی تامین
The Pharmaceutical Investment Company bought 3254.644 million shares of Hijra on 14/05/22 and currently holds 17.084 % of Hijra's shares in its portfolio.
شرکت داروسازی تهران شیمی
Tehran Pharmaceutical Chemistry Company purchased 4427.465 million shares of Hijra on 14/05/22 and currently holds 23.241 % of Hijra's shares in its equity portfolio.
شرکت داروسازی فارابی
Farabi Pharmaceutical Company bought 4615.478 million shares of Hijra on 22/05/22 and currently holds 24.228 % of Hijra's shares in its portfolio.
صندوق سرمایه گذاری مشترک پیشرومفید
The Plethophid Joint Investment Fund bought 193.437 million shares of Hijra on 14/05/22 and currently holds 1.015 percent of Hijra's shares in its equity portfolio.
شرکت پارس دارو
Pars Daru Company bought 2311.215 million shares of Hijra on 22/05/22 and currently holds 12.132 % of Hijra's shares in its corporate portfolio.
صندوق سرمایه گذاری مشترک پیشرو
The Pioneer Joint Investment Fund bought 0.057 million shares of Hijra on 14/10/24 and currently holds 1.015 percent of Hijra's shares in its joint stock portfolio.
شرکت پارس دارو
Pars Daru Company sold 3.800 million shares of Hijra on 14/10/23 and currently holds 12.132 % of Hijra's shares in its joint portfolio.
شرکت پارس دارو
Pars Daru Company has sold 4,000 million shares of Hijra on 14/10/22 and currently holds 12.369 % of Hijra's shares in its joint portfolio.
شرکت پارس دارو
Pars Daru Company sold 3.000 million shares of Hijra on 14/10/19 and currently holds 12.619 % of Hijra's shares in its joint portfolio.
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.